News und Analysen
![Novus Therapeutics Announces Acquisition of Anelixis Therapeutics](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical stage biotechnology company
![Sunesis Pharmaceuticals: Risikoarmes "Peak Play" mit Multibagger-Potenzial](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Sunesis Pharmaceuticals: Risikoarmes "Peak Play" mit Multibagger-Potenzial
Die Aktie des an der Nasdaq handelnden Krebsforschers Sunesis Pharmaceuticals (WKN: A2QEPW) ist günstiger als jemals zuvor. Wer auf dem aktuellen Kursniveau investiert, bekommt nicht nur Geld
![VALBIOTIS Receives US and European TOTUM-070 Patent for Reducing Hypercholesterolemia](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
VALBIOTIS Receives US and European TOTUM-070 Patent for Reducing Hypercholesterolemia
Regulatory News:
VALBIOTIS (Paris:ALVAL) (FR0013254851 - ALVAL, eligible for the PEA/SME), a Research & Development company committed to scientific innovation for preventing and combating
![Seattle Genetics: Megadeal mit Merck & Co!](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Seattle Genetics: Megadeal mit Merck & Co!
Zu den größten Gewinnern am US-Aktienmarkt zählt heute die Aktie des Biotechunternehmens Seattle Genetics (WKN: 602322). Grund hierfür ist ein milliardenschwerer Megadeal mit dem ebenfalls
![Pfizer Hosts Virtual Investor Day](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Pfizer Hosts Virtual Investor Day
Pfizer Inc. (NYSE: PFE) will host its virtual Investor Day today and tomorrow: Monday, September 14, 2020 from 1:00 p.m. EDT to 3:45 p.m. EDT and Tuesday, September 15, 2020 from 10:00 a.m. EDT to
![STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that patient enrollment
![NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the establishment of the GeoMx Premier Access Sites
![Gilead schluckt Immunomedics: +108% nach neuer Biotech-Übernahme](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Gilead schluckt Immunomedics: +108% nach neuer Biotech-Übernahme
Biotech bleibt heiß: Mit der Übernahme des Krebsspezialisten Immunomedics (WKN: 872983) durch den Pharmariesen Gilead Sciences (WKN: 885823) feiert der Sektor eine weitere Knallerstory. Das Angebot
![Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced today that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase
![Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the J.P. Morgan 11th Annual U.S
![Drägerwerk: Regierung storniert – Sonderkonjunktur adé?](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
Drägerwerk: Regierung storniert – Sonderkonjunktur adé?
Die Beatmungsgeräte Drägerwerks (WKN: 555060) waren gefragt wie nie und so die Aktien des Medizintechnik-Herstellers. Nun ebbt die Nachfrage ab. Drägerwerk-Papiere verlieren heute den zweiten Tag in
![Sangamo Therapeutics Appoints Kenneth Hillan to Its Board of Directors](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Sangamo Therapeutics Appoints Kenneth Hillan to Its Board of Directors
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Dr. Kenneth Hillan, an accomplished biotechnology executive, to the Company's Board of
![Savara Announces Senior Management Changes](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Savara Announces Senior Management Changes
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that Rob Neville has resigned as the Company’s Chief Executive Officer (CEO) and from the Board of Directors, effective
![Relay Medical und Fio Corporation geben Auslieferung der ersten Fionet-COVID-19-Workflow-Software an Gesundheitseinrichtungen in Kenia bekannt](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Relay Medical und Fio Corporation geben Auslieferung der ersten Fionet-COVID-19-Workflow-Software an Gesundheitseinrichtungen in Kenia bekannt
- Relay und Fio haben die erste Fionet-COVID-19-Software an das Gesundheitsministerium von Meru County in Kenia, das auf regionaler Ebene ein Netzwerk von rund 140
![Relay Medical and Fio Corporation Announce Delivery of First Fionet COVID-19 Workflow Software to Healthcare Clinics in Kenya](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Relay Medical and Fio Corporation Announce Delivery of First Fionet COVID-19 Workflow Software to Healthcare Clinics in Kenya
- Relay and Fio announce delivery of first Fionet COVID-19 software for Meru County Ministry of Health, which operates a network of approximately 140 clinics in Meru County, Kenya
![Humana Announces Launch of Two National Value-Based Programs](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Humana Announces Launch of Two National Value-Based Programs
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced an expansion of its value-based program portfolio with the creation of two national programs for members of select
![Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting
Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that an abstract featuring data from an exploratory analysis of the ARIEL3 clinical study evaluating Rubraca® (rucaparib) as maintenance
![Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020
Pfizer Inc. (NYSE:PFE) announced today that more than 50 abstracts representing data from nine approved and investigational Pfizer medicines, including several biomarker-driven and
![Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the senior management team will participate in fireside chats during the following upcoming
![NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present
![Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that Savara management will be presenting at the H.C. Wainwright Annual Investment Conference on Wednesday, September 16
![Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that company
![Transgene Announces Upcoming Investor Meetings](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Transgene Announces Upcoming Investor Meetings
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that Management will
![THERANEXUS PRESENTS ITS LATEST SCIENTIFIC NEWS](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
THERANEXUS PRESENTS ITS LATEST SCIENTIFIC NEWS
- New research partnership with the University of Lyon (CERMEP)
- New scientific publications
- Presentation at the European Congress of Neuropsychopharmacology (ECNP)
Lyon, 9 September 2020 –
![BOIRON : 2020 half-year results](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
BOIRON : 2020 half-year results
(Data have been the subject to a limited review by the statutory auditors)
The Board of Directors, at its meeting of September 9, 2020, made up the half-year statutory and consolidated financial